Pine Pharmaceuticals, LLC

Complete recall history across all FDA and CPSC categories — 24 total recalls

Pine Pharmaceuticals, LLC appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (24)

FDA drug safety enforcement actions by Pine Pharmaceuticals, LLC

Date Product Reason Class
Oct 2, 2023 Tropi-Phen (Tropicamide 1% phenylephrine HCl 2.5%) ophthalmic solution, 15 mL... Lack of Assurance of Sterility Class II
Oct 2, 2023 Foscarnet Sodium 2.4mg/0.1 mL solution for injection, 0.2 mL single-dose Sta... Lack of Assurance of Sterility Class II
Oct 2, 2023 Endophth Kit (Vancomycin 1mg/0.1 mL - Ceftazidime 2.25mg/0.1 mL), Rx only, Co... Lack of Assurance of Sterility Class II
Oct 2, 2023 Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, C... Lack of Assurance of Sterility Class II
Oct 2, 2023 Tropi-Phen (tropicamide 1%, phenylephrine 2.5%) ophthalmic solution, 5mL mult... Lack of Assurance of Sterility Class II
Oct 2, 2023 Vancomycin 1 MG/0.1 ML Solution for Intraocular Injection, 0.8 ML Single Dose... Lack of Assurance of Sterility Class II
Oct 2, 2023 Calcium Gluconate 2.5% solution for inhalation, 5mL pre-filled syringes, Rx o... Lack of Assurance of Sterility Class II
Oct 2, 2023 Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal adminis... Lack of Assurance of Sterility Class II
Oct 2, 2023 Calcium Gluconate Ophthalmic Irrigation Solution 1%, 500 mL bags, Rx only, C... Lack of Assurance of Sterility Class II
Oct 2, 2023 TPC Drops (tropicamide 1%- phenylephrine 2.5%- cyclopentolate HCl 1% ophthalm... Lack of Assurance of Sterility Class II
Oct 2, 2023 Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 6... Lack of Assurance of Sterility Class II
Oct 2, 2023 Lidocaine HCl 4% ophthalmic solution, 3 mL single-use dropper, Rx only, Compo... Lack of Assurance of Sterility Class II
Oct 2, 2023 Calcium chloride Solution for Intravenous Injection, 20 mg/mL, 500 mL bags, R... Lack of Assurance of Sterility Class II
Oct 2, 2023 Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL s... Lack of Assurance of Sterility Class II
Oct 2, 2023 Cefuroxime 4mg /0.4 mL (10 mg/mL), 1mL syringe, Rx only, Compounded by: Pine ... Lack of Assurance of Sterility Class II
Oct 2, 2023 Lidocaine-phenylephrine 1%-1.5% 1mL Single Dose Vial, Rx only, Compounded by ... Lack of Assurance of Sterility Class II
Mar 27, 2023 Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip ... Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packa... Class III
Dec 22, 2022 Epi-Caine, Epinephrine 0.025% Lidocaine HCL 0.75% Solution for Intraocular In... CGMP Deviations: Raw material recalled by repackager, due to discoloration. Class II
Jul 27, 2022 Bupivacaine HCl 0.375% w/v and Lidocaine HCl 2% w/v Solution for Retrobulbar ... Lack of Assurance of Sterility Class II
Mar 5, 2018 Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL Compounded ... Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxil... Class III
Nov 4, 2015 Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe f... Presence of particulate matter: Presence of silicone oil microdroplets in bev... Class II
Nov 4, 2015 Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal inje... Presence of particulate matter: Presence of silicone oil microdroplets in bev... Class II
Nov 4, 2015 Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -... Presence of particulate matter: Presence of silicone oil microdroplets in bev... Class II
Nov 4, 2015 Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx... Presence of particulate matter: Presence of silicone oil microdroplets in bev... Class II

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.